Hims & Hers Health, Inc.·4

Jun 17, 6:51 PM ET

Carroll Patrick Harrison 4

Research Summary

AI-generated summary

Updated

HIMS CMO Patrick Harrison Receives RSU Shares; Shares Withheld

What Happened

  • Carroll Patrick Harrison, Chief Medical Officer of Hims & Hers Health, had 25,926 restricted stock units (RSUs convert/settle into Class A common shares) vest/convert on June 15, 2026. Of those shares, 8,310 were withheld and sold to cover tax withholding obligations for proceeds of approximately $250,713 (sale price reported at $30.17 per share). The net shares delivered to Harrison after withholding were 17,616 (25,926 gross − 8,310 withheld).
  • This was a vesting/settlement of RSUs (derivative conversion), not an open-market purchase or voluntary sale by the insider; the withholding is a routine tax-related disposition.

Key Details

  • Transaction date: June 15, 2026; Form 4 filed June 17, 2026 (timely filing).
  • Gross shares from RSU settlement: 25,926 shares converted to Class A common stock.
  • Shares withheld/sold for taxes: 8,310 shares at $30.17 per share, totaling ~$250,713.
  • Net shares delivered to insider: 17,616 shares (not a market sell initiated by the insider beyond required tax withholding).
  • Footnotes: RSUs represent contingent rights to one share each; issuer withheld shares to satisfy tax withholding. RSUs are subject to multi-year service-based vesting schedules (see filing footnotes for grant-specific vesting start dates).
  • Shares owned after the transaction: Not specified in this Form 4.

Context

  • This is a routine RSU vesting and tax-withholding transaction. When RSUs settle, companies commonly withhold or sell a portion of shares to cover payroll/tax obligations; that action should not be read as a voluntary "sell" indicating changed insider sentiment.
  • The filing shows a derivative conversion (M code) and a tax-withholding disposition (F code). The $250K figure reflects the tax withholding sale proceeds, not an independent cash sale by the insider.